Colorectal cancer stage iii and Gastrointestinal inflammation

Summary:

Gastrointestinal inflammation is reported only by a few people with Colorectal cancer stage iii.

The study analyzes which people have Gastrointestinal inflammation with Colorectal cancer stage iii. It is created by eHealthMe based on 1 person who has Gastrointestinal inflammation and Colorectal cancer stage iii from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 18, 2022

1 person who has Colorectal Cancer Stage Iii and Gastrointestinal Inflammation is studied.

What is Colorectal cancer stage iii?

Colorectal cancer stage iii (colon and rectal cancer spreads to lymph nodes) is found to be associated with 40 drugs and 13 conditions by eHealthMe.

What is Gastrointestinal inflammation?

Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 774 drugs and 512 conditions by eHealthMe.

Number of Gastrointestinal inflammation in Colorectal cancer stage iii reports submitted per year:

Would you have Gastrointestinal inflammation when you have Colorectal cancer stage iii?

Gender of people who have Colorectal Cancer Stage Iii and experienced Gastrointestinal Inflammation *:

female: 0.0 %
male: 100 %

Age of people who have Colorectal Cancer Stage Iii and experienced Gastrointestinal Inflammation *:

Common co-existing conditions for these people *:

Colon Cancer: 1 person, 100.00%

Common drugs taken by these people *:

Xeloda: 1 person, 100.00%
Oxaliplatin: 1 person, 100.00%

Common symptoms for these people *:

Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 100.00%
Bone Marrow Failure: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gastrointestinal inflammation?

Check whether Gastrointestinal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, "Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn9s disease", Gut, 2016 Mar .

Related studies

Treatments, associated drugs and conditions:

Colorectal cancer stage iii (4,038 reports)
Gastrointestinal inflammation (7,706 reports)

COVID vaccines that are related to Gastrointestinal inflammation:

Common drugs associated with Gastrointestinal inflammation:

Amlodipine: 113 reports
Aspirin: 187 reports
Calcium: 154 reports
Cyclophosphamide: 139 reports
Enbrel: 126 reports
Humira: 2,862 reports
Ibu: 118 reports
Ibuprofen: 125 reports
Imuran: 166 reports
Metformin: 113 reports
Methotrexate: 461 reports
Morphine: 111 reports
Nexium: 143 reports
Omeprazole: 285 reports
Pantoprazole: 207 reports
Pentasa: 133 reports
Prednisone: 611 reports
Remicade: 268 reports
Synthroid: 127 reports
Tramadol: 104 reports
Tylenol: 121 reports
Vitamin b12: 142 reports
Vitamin d: 213 reports

How the study uses the data?

The study is based on Gastrointestinal inflammation and Colorectal cancer stage iii, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.